Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Oslo University Hospital

Division of University of Oslo
www.oslo-universitetssykehus.no

Latest From Oslo University Hospital

PROFNAIT: Collaborating To Combat Rare Disease

Prophylix Pharma is set to be the first company to begin clinical trials for a prophylactic for fetal and neonatal alloimmune thrombocytopenia, a rare but serious disorder that can cause serious bleeding in babies' brains. Its candidate, NAITgam, is being developed under the auspices of the PROFNAIT consortium, an innovative collaborative project involving 11 Northern European universities, hospitals, research organizations, companies, and blood banks.

BioPharmaceutical

Vaccibody AS

Vaccibody AS’ platform can develop vaccines that can drive the immune response in specific directions and thus optimize the vaccine for different diseases – for example, toward the T-cell cell-mediated response for therapeutic vaccines, or the B-cell antibody-mediated response for prophylactic vaccines. The start-up’s lead vaccine is a therapeutic one, targeting precancerous lesions and malignancies in the cervix caused by human papillomavirus. Safety and toxicity studies are under way, and clinical trials are planned for early 2014.

BioPharmaceutical

Recent Tech Transfer Deals, April 2012

START-UP ’s monthly update on technology transfer deals--licensing agreements between companies and universities or other research institutions—in in vitro diagnostics, pharmaceuticals, research/analytical equipment & supplies, and medical devices.

BioPharmaceutical Medical Device

Medical Device Deals Update, March 2012

A roundup of recent medtech mergers & acquisitions, strategic alliances, and financings.

Medical Device
See All
Advertisement
Advertisement
UsernamePublicRestriction

Register